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SIDE EFFECT OF 5-HYDROXYTRIPTAMINE3 RECEPTOR ANTAGONIST IN THE
PROPHYLACTIC TREATMENT OF EMESIS INDUCED BY CISPl-ATIN AND TAXOTERE
CHEMOTHERAPY: A CASE REPORT'
..
The 5-hydroxytryptamine3 receptor (5-HT3receptor) antagonists recently has been developed as a class of
new anti-emetic agent These drugs were initially found to prevent vomiting due to Cisplatin, a
chemotherapeutic drug with strong emetic effect, but subsequent clinical studies have shown that 5-HT3
receptor afi1agonist are also effective in controlling vomiting-due to other anti cancer drugs and
radiotherapy. .
A 45 years old malay female was admitted for frrst cycle of Cisplatin and Docetaxel chemotherapy
trea~ent for her right side breast cancer. She had diagnosed to have right site ofmedullary breast ca.ticer.
Previously she had been surgically treated of her breast cancer followed by radiation three years ago.
Adriamycin and Cyclophosphamide Chemotherapy regimeb,ad been given over 4 cycles. A next year
follow-up investigation, included surgical biopsy didn't show neither any residual tumour nor lymph
nodes involvement, Chest X ray, abdomen Ultrasonography and Mammography showed no evident of
inetas~is. Fine Niddle Aspiration Cytologic also didn't find diagnostic material. Unfortunately, she
currently complained ofpain at her chest and back. Furhter, bone scan had investigated increase in uptake
of tracer or infiltration to the 6d1 rib of sternum. CT-thorax showed there is soft tissue mass at the right
anterior chest wall involving the pectoralis major muscle. This is the latest diagnosed as a recurrent
cancer with early metastasis.
On this r~ime,cisplatinwas given 110 mgin I L normal.saline for 3 hours and Taxotere 110 g in 500 ml
for 1 hour. Intravenous 5-lIT3·receptor antagonist (Gi1lnisetronR) 3 mg with IV Dexametbason~mg and
Dexamethason tablet 4 mg QID were given half hour prior the -chemotherapy. Other medications given
before chemo included Voltaren tablet 50 mgtds, Lactulose syrup 20 ml ON and Dihydrocodein 30 mg
tds. During received this chemotherapy, generally patient was comfortable and did not complaint nausea
and vo~ting until complete cycle, but one day after this cycle patient complained of constipation and
headache.
Cisplatin and T~otere chemotherapy are effective in breast cancer but however, the side effect of this
treatment include potentially debilitating nausea and vomiting. Successful anti emetic therapy can enable
patients receiving chemotherapy to maintain and improve their quality of life
